Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPFRONT-SIP
NCT07907120Phase 4Not yet recruiting
- Sponsor
- Jamia Millia Islamia
- Start
- Oct 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 4 trial of articaine, lidocaine in irreversible pulpitis, sponsored by Jamia Millia Islamia. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
articainelidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07907120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907120.